| Aaron Z Grabovich, ANASST | |
|
500 S Cleveland Ave, Westerville, OH 43081-8971 | |
| (614) 898-6659 | |
| (614) 898-8631 |
| Full Name | Aaron Z Grabovich |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology Assistant |
| Experience | 15 Years |
| Location | 500 S Cleveland Ave, Westerville, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841524733 | NPI | - | NPPES |
| 3031436 | Medicaid | OH | |
| XXXXX1010-00 | Other | OH | OHIO BWC |
| 000000750354 | Other | OH | ANTHEM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | 67.000158 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mount Carmel St Ann's | Westerville, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Consultant Anesthesiologists Inc. | 3577467109 | 62 |
News Archive
A new study published this week in the Journal of Neurosurgery: Pediatrics finds that operative plans for removing Juvenile Pilocytic Astrocytoma, or JPA, tumors in the thalamus of the brain can be augmented with Diffusion Tensor Imaging, or DTI. The sensitivity of DTI imaging allows for the visualization of nerve fiber bundles in the brain.
The biological mechanism of sunburn - the reddish, painful, protective immune response from ultraviolet (UV) radiation - is a consequence of RNA damage to skin cells, report researchers at the University of California, San Diego School of Medicine and elsewhere in the July 8, 2012 Advance Online Publication of Nature Medicine.
Cancer treatments have many effects on patients – some apparent and some less so. One of the most noticeable changes is a change in taste.
EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, announced today that, following a recent meeting with the U.S. Food and Drug Administration (FDA) to discuss the Company's EMPOWER™ study results and the regulatory process, the Company intends to submit an Investigational Device Exemption (IDE) application for a clinical trial to support a possible Premarket Approval (PMA) application for the next-generation Maestro® RC System in the treatment of morbid obesity.
In order to combine forces on expanding CAD technology, Merge Healthcare Incorporated, a leading health IT solutions provider, and Confirma, Inc., the largest privately-held developer of computer assisted detection (CAD) software for medical imaging, announce that they have entered into a definitive agreement for Merge to acquire Confirma in an all-stock transaction. This acquisition brings Confirma's patented and proven technologies to Merge's multiple market channels and international markets, and provides a mechanism to expand adoption of this important technology.
› Verified 6 days ago
| Entity Name | Consultant Anesthesiologists Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457420580 PECOS PAC ID: 3577467109 Enrollment ID: O20031125000053 |
News Archive
A new study published this week in the Journal of Neurosurgery: Pediatrics finds that operative plans for removing Juvenile Pilocytic Astrocytoma, or JPA, tumors in the thalamus of the brain can be augmented with Diffusion Tensor Imaging, or DTI. The sensitivity of DTI imaging allows for the visualization of nerve fiber bundles in the brain.
The biological mechanism of sunburn - the reddish, painful, protective immune response from ultraviolet (UV) radiation - is a consequence of RNA damage to skin cells, report researchers at the University of California, San Diego School of Medicine and elsewhere in the July 8, 2012 Advance Online Publication of Nature Medicine.
Cancer treatments have many effects on patients – some apparent and some less so. One of the most noticeable changes is a change in taste.
EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, announced today that, following a recent meeting with the U.S. Food and Drug Administration (FDA) to discuss the Company's EMPOWER™ study results and the regulatory process, the Company intends to submit an Investigational Device Exemption (IDE) application for a clinical trial to support a possible Premarket Approval (PMA) application for the next-generation Maestro® RC System in the treatment of morbid obesity.
In order to combine forces on expanding CAD technology, Merge Healthcare Incorporated, a leading health IT solutions provider, and Confirma, Inc., the largest privately-held developer of computer assisted detection (CAD) software for medical imaging, announce that they have entered into a definitive agreement for Merge to acquire Confirma in an all-stock transaction. This acquisition brings Confirma's patented and proven technologies to Merge's multiple market channels and international markets, and provides a mechanism to expand adoption of this important technology.
› Verified 6 days ago
| Entity Name | Osu Observation Medicine, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407095052 PECOS PAC ID: 3375692270 Enrollment ID: O20090526000354 |
News Archive
A new study published this week in the Journal of Neurosurgery: Pediatrics finds that operative plans for removing Juvenile Pilocytic Astrocytoma, or JPA, tumors in the thalamus of the brain can be augmented with Diffusion Tensor Imaging, or DTI. The sensitivity of DTI imaging allows for the visualization of nerve fiber bundles in the brain.
The biological mechanism of sunburn - the reddish, painful, protective immune response from ultraviolet (UV) radiation - is a consequence of RNA damage to skin cells, report researchers at the University of California, San Diego School of Medicine and elsewhere in the July 8, 2012 Advance Online Publication of Nature Medicine.
Cancer treatments have many effects on patients – some apparent and some less so. One of the most noticeable changes is a change in taste.
EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, announced today that, following a recent meeting with the U.S. Food and Drug Administration (FDA) to discuss the Company's EMPOWER™ study results and the regulatory process, the Company intends to submit an Investigational Device Exemption (IDE) application for a clinical trial to support a possible Premarket Approval (PMA) application for the next-generation Maestro® RC System in the treatment of morbid obesity.
In order to combine forces on expanding CAD technology, Merge Healthcare Incorporated, a leading health IT solutions provider, and Confirma, Inc., the largest privately-held developer of computer assisted detection (CAD) software for medical imaging, announce that they have entered into a definitive agreement for Merge to acquire Confirma in an all-stock transaction. This acquisition brings Confirma's patented and proven technologies to Merge's multiple market channels and international markets, and provides a mechanism to expand adoption of this important technology.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Aaron Z Grabovich, ANASST 6780 Clear Creek Loop, Powell, OH 43065-8435 Ph: (614) 537-0859 | Aaron Z Grabovich, ANASST 500 S Cleveland Ave, Westerville, OH 43081-8971 Ph: (614) 898-6659 |
News Archive
A new study published this week in the Journal of Neurosurgery: Pediatrics finds that operative plans for removing Juvenile Pilocytic Astrocytoma, or JPA, tumors in the thalamus of the brain can be augmented with Diffusion Tensor Imaging, or DTI. The sensitivity of DTI imaging allows for the visualization of nerve fiber bundles in the brain.
The biological mechanism of sunburn - the reddish, painful, protective immune response from ultraviolet (UV) radiation - is a consequence of RNA damage to skin cells, report researchers at the University of California, San Diego School of Medicine and elsewhere in the July 8, 2012 Advance Online Publication of Nature Medicine.
Cancer treatments have many effects on patients – some apparent and some less so. One of the most noticeable changes is a change in taste.
EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, announced today that, following a recent meeting with the U.S. Food and Drug Administration (FDA) to discuss the Company's EMPOWER™ study results and the regulatory process, the Company intends to submit an Investigational Device Exemption (IDE) application for a clinical trial to support a possible Premarket Approval (PMA) application for the next-generation Maestro® RC System in the treatment of morbid obesity.
In order to combine forces on expanding CAD technology, Merge Healthcare Incorporated, a leading health IT solutions provider, and Confirma, Inc., the largest privately-held developer of computer assisted detection (CAD) software for medical imaging, announce that they have entered into a definitive agreement for Merge to acquire Confirma in an all-stock transaction. This acquisition brings Confirma's patented and proven technologies to Merge's multiple market channels and international markets, and provides a mechanism to expand adoption of this important technology.
› Verified 6 days ago
Maria C. Fortner, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 500 S Cleveland Ave, Westerville, OH 43081 Phone: 380-898-4000 | |
Scott Vazquez, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 500 S Cleveland Ave, Westerville, OH 43081 Phone: 380-898-4000 | |
Addison E Cain, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 500 S Cleveland Ave, Westerville, OH 43081 Phone: 380-989-4000 | |
Jane S. Tukys, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 500 S Cleveland Ave, Westerville, OH 43081 Phone: 614-898-4000 | |
Inga Davis, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 500 S Cleveland Ave, Coa-anesthesia Dept, Westerville, OH 43081 Phone: 614-898-6659 Fax: 614-898-8631 | |
Gretchen M Heringhaus, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 500 S Cleveland Ave, Anesthesia Dept/coa, Westerville, OH 43081 Phone: 614-898-6659 Fax: 614-898-8631 |